Abstract:Platelet‐derived growth factor (PDGF), is one of the major growth factors found in mammalian serum, which plays an important role in cell growth. It has been previously demonstrated that abnormal activation of the PDGF signaling pathway can contribute to aberrant pulmonary vascular remodeling and pulmonary hypertension via active PDGF receptors. The overall goal of this study was to examine the expression of the PDGFR isoforms in both pulmonary artery smooth muscle cells (PASMC) and pulmonary artery endothelial cells (PAEC) and to identify whether PDGF produced in PASMC or PAEC promotes PASMC cell proliferation. We observed that the protein and mRNA expression level of both PDGFRα and PDGFRβ were upregulated in IPAH patients in comparison to normal PASMC. However, expression of PDGFRα and PDGFRβ was not detected in PAEC. PDGF treatment enhanced the activity of PDGFRα and PDGFRβ, as determined by phosphorylation of PDGFRα and PDGFRβ in IPAH PASMC compared to control. Furthermore, the PDGF‐induced rise in cytosolic free Ca2+ was also increased in IPAH PASMC in comparison to normal PASMC. Treatment with normal PAEC cultured conditioned medium enhanced PDGFRα activation in IPAH PASMC than normal PASMC, while normal PASMC cultured conditioned medium had no effect on p‐PDGFRα and p‐PDGFRβ. We further found that the expression level of PDGFA and PDGFB were increased in IPAH PAEC compare to normal PAEC. Additionally, the expression level of PDGFA and PDGFB in PAEC were increased in normoxic condition compare to hypoxia. Normal PAEC cultured conditioned medium promotes cell proliferation in PASMC; proliferation was markedly higher in IPAH PAEC cultured conditioned medium, but not in PASMC cultured conditioned medium. The data showed that the expression and activity of PDGF receptor were increased in IPAH PASMC. Overall these results suggest that IPAH PAEC secret high‐levels of PDGF to the PASMC, which can affect active PDGF receptor, promoting PASMC proliferation which can lead to pulmonary hypertension.Support or Funding InformationThis study was supported in part by the grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL135807 and HL125208), the National Natural Science Foundation of China (81630004, 81470246, 81220108001 and 81520108001), the Guangzhou Department of Education Yangcheng Scholarship (12A001S), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme of China, China Scholarship Council (201608440324) and the Actelion ENTELLIGENCE Young Investigator Award.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

The effection of idiopathic pulmonary hypertension on endothelial progenitor cells and bone morphogenetic protein-2

Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension.

Paracrine Effects Of Bone Marrow-Derived Endothelial Progenitor Cells: Cyclooxygenase-2/Prostacyclin Pathway In Pulmonary Arterial Hypertension

Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study

Endothelial Progenitor Cells May Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells: New Insights into Cell Therapy for Pulmonary Arterial Hypertension

Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension

[Effects of Angiotensin II on Peripheral Blood Endothelial Progenitor Cells].

Overexpression of ACE2 Prevents Hypoxia-Induced Pulmonary Hypertension in Rats by Inhibiting Proliferation and Immigration of PASMCs.

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy

Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection

The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease

A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension

Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension.

Bone Morphogenetic Protein 2 Decreases TRPC Expression, Store-Operated Ca(2+) Entry, and Basal [ca(2+)]i in Rat Distal Pulmonary Arterial Smooth Muscle Cells.

Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension

Intravenous infusion of autologous endothelial progenitor cells in treatment of primary pulmonary hypertension

PARACRINE ACTION ACCOUNTS FOR MARKED PROTECTION OF MONOCROTALINE-INDUCED PULMONARY ARTERIAL HYPERTENSION BY BONE MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS

Expression pattern of the bone morphogenetic protein-4 and its relationship with inflammation, vascular injury in patients suffered the arterial occlusive diseases

Increased bone morphogenetic protein 10 in precapillary pulmonary hypertension patients

Endothelial‐dependent Activation of Smooth Muscle PDGF Receptors Enhances PASMC Proliferation in IPAH

Elevated Levels of Circulating BMP7 Predict Mortality in Pulmonary Arterial Hypertension